Why the study?
Does irbesartan reduce albumin excretion rate and blood pressure in microalbuminuric hypertensive and normotensive type 2 diabetic patients?
Does irbesartan reduce albumin excretion rate and blood pressure in microalbuminuric hypertensive and normotensive type 2 diabetic patients?
Irbesartan reduces albumin excretion rate in microalbuminuric type 2 diabetic patients regardless of their blood pressure status, demonstrating a renoprotective effect independent of blood pressure lowering.
No takes yet. Share an insight, caveat, or question.
Supports irbesartan to reduce albuminuria in microalbuminuric type 2 diabetes regardless of hypertension status; extends evidence for blood pressure-independent renoprotection.
Sasso et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: